The FDA says there is limited evidence to support health claims that whole-grain consumption can reduce diabetes risk, and that it will use its enforcement discretion for two food-label claims that whole grains may reduce the risk of type 2 diabetes. Food manufacturers are permitted to make the claims if they are worded in a manner that does not mislead consumers.
FDA to use enforcement discretion on whole-grains health claims
SmartBrief Job Listings for Health Care
|Director, Medicare Advantage/Medicare Part D Focus||
|Director of Clinical Research||
Regenesis Biomedical, Inc.
|Chief, Product Review Branch||
FDA/Center for Biologics Evaluation and Research
|Silver Spring, MD|
|Assistant Vice President - Dental Director||